References
- MiniñoAMXuJKochanekKDDeaths: Preliminary data for 2008. National Vital Statistics ReportsHyattsville, MDNational Center for Health Statistics201059215225073655
- Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for diagnosis, management and prevention of COPD2015 Available from: http://goldcopd.org/gold-reports/Accessed October 25, 2016
- National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI)Morbidity and Mortality: 2009 Chart Book on Cardiovascular, Lung and Blood DiseasesBethesda, MDNHLBI2009
- AnderssonFBorgSJanssonSAThe costs of exacerbations in chronic obstructive pulmonary disease (COPD)Respir Med200296970070812243316
- ToyELGallagherKFStanleyELSwensenARDuhMSThe economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a reviewCOPD20107321422820486821
- YeawJBennerJSWaltJGSianSSmithDBComparing adherence and persistence across 6 chronic medication classesJ Manag Care Pharm200915972874019954264
- CramerJABenedictAMuszbekNKeskinaslanAKhanZMThe significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a reviewInt J Clin Pract2008621768717983433
- NeugaardBIPriestJLBurchSPCantrellCRFoulisPRQuality of care for veterans with chronic diseases: performance on quality indicators, medication use and adherence, and health care utilizationPopul Health Manag20111429910621091367
- GeorgeJKongDCThomanRStewartKFactors associated with medication nonadherence in patients with COPDChest200512853198320416304262
- MenzinJBoulangerLMartonJThe economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare populationRespir Med200810291248125618620852
- KrigsmanKMoenJNilssonJLRingLRefill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year periodJ Clin Pharm Ther200732660361118021338
- FordESMurphyLBKhavjouOGilesWHHoltJBCroftJBTotal and state-specific medical and absenteeism costs of COPD among adults aged ≥18 years in the United States for 2010 and projections through 2020Chest20151471314525058738
- World Health OrganizationAdherence to long-term therapies: evidence for actionGeneva, SwitzerlandWorld Health Organization2003 Available from: http://apps.who.int/iris/bitstream/10665/42682/1/9241545992.pdfAccessed March 2, 2016
- LeslieRSUsing arrays to calculate medication utilizationProceedings from the 2007 SAS Global Forum2007Orlando, FLPaper 043-2007 Available from: http://www.lexjansen.com/pharmasug/2008/pr/pr07.pdfAccessed November 28, 2016
- FarleyJFHarleyCRDevineJWA comparison of comorbidity measurements to predict healthcare expendituresAm J Manag Care200612211011916464140
- MakeBDutroMPPaulose-RamRMartonJPMapelDWUnder-treatment of COPD: a retrospective analysis of US managed care and Medicare patientsInt J Chron Obstruct Pulmon Dis201271922315517
- TanziMGCounseling to enhance medication adherence2012 Available from: https://www.pharmacist.com/counseling-enhance-medication-adherenceAccessed November 28, 2016
- FordESMurphyLBKhavjouOGilesWHHoltJBCroftJBTotal and state-specific medical and absenteeism costs of COPD among adults aged ≥18 years in the United States for 2010 and projections through 2020Chest20151471314525058738
- Chronic obstructive pulmonary disease among adults – United States, 2011Morb Mortal Wkly Rep20126146938943